UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
May 2, 2014
Date of Report (Date of earliest event reported)
| PETVIVO HOLDINGS, INC. |
| (Exact name of registrant as specified in its charter) |
| Nevada | | 333-173569 | | 99-0363559 |
| (State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
12100 Singletree Lane, Suite 186 Eden Prairie, Minnesota | | 55344 |
| (Address of principal executive offices) | | (Zip Code) |
(612) 296-7305
Registrant’s telephone number, including area code
Technologies Scan Corp.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 8.01 Other Events
On April 29, 2014, the Company’s name change from Technologies Scan Corp to “PetVivo Holdings, Inc.” was declared effective by FINRA, and the Company’s common stock trading symbol was changed to “PETV.”
PetVivo is based in Minneapolis, Minnesota and is an emerging biomedical device company focusing on the licensing and commercialization of innovative therapeutic medical devices for pets and other animals. Using its licensed patented technology, PetVivo intends to leverage developed advances in human bio-materials and the medical device industry to profitably commercialize and market healthcare treatments for pets and other animals.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | PETVIVO HOLDINGS, INC. | |
| | | | |
| Date: May 2, 2014 | By: | /s/ John Lai | |
| | Name: | John Lai | |
| | Title: | President/Chief Executive Officer | |
